Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure
International Journal of Molecular Sciences · 03.02.2025 · 26 (3) · 1295
DOI: 10.3390/ijms26031295 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2025. Verfasst von Jenny Valentina Garmendia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic. Hauptthemen laut MEDLINE: Abortion, Habitual, Embryo Implantation. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 411 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Youth, and Sport, Czech Republic., National Institute of Virology and Bacteriology, Ministry of Education, Youth, and Sport, Czech Republic: Molecular and Cellular Clinical Approach to Healthy Ageing, ENOCH.
Abstract (Originalsprache)
Recurrent pregnancy loss (RPL) is defined as the occurrence of two or more consecutive pregnancy losses before 24 weeks of gestation. It affects 3–5% of women who are attempting to conceive. RPL can stem from a variety of causes and is frequently associated with psychological distress and a diminished quality of life. By contrast, recurrent implantation failure (RIF) refers to the inability to achieve a successful pregnancy after three or more high-quality embryo transfers or at least two instances of egg donation. RIF shares several causative factors with RPL. The immunological underpinnings of these conditions involve alterations in uterine NK cells, reductions in M2 macrophages and myeloid-derived suppressor cells, an increased Th1/Th2 ratio, a decreased Treg/Th17 ratio, the presence of shared ≥3 HLA alleles between partners, and autoimmune disorders. Various therapeutic approaches have been employed to address these immunological concerns, achieving varying degrees of success, although some therapies remain contentious within the medical community. This review intends to explore the immunological factors implicated in RPL and RIF and to analyze the immunological treatments employed for these conditions, which may include steroids, intravenous immunoglobulins, calcineurin inhibitors, anti-TNF antibodies, intralipid infusions, granulocyte colony-stimulating factor, and lymphocyte immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
- Czech Advanced Technologies and Research Institute (CATRIN), Institute of Molecular and Translational Medicine, 779 00 Olomouc, Czech Republic.
- Laboratory of Experimental Medicine, University Hospital Olomouc, 779 00 Olomouc, Czech Republic.
ORCID-Profile: Jenny Valentina Garmendia, Claudia Valentina De Sanctis, Marián Hajdúch, Juan Bautista De Sanctis
Förderung
- Ministry of Education, Youth, and Sport, Czech Republic.
- National Institute of Virology and Bacteriology
- Ministry of Education, Youth, and Sport, Czech Republic: Molecular and Cellular Clinical Approach to Healthy Ageing, ENOCH
- European Union
Zitieren
APA
Garmendia, J. V., De Sanctis, C. V., Hajdúch, M., & De Sanctis, J. B. (2025). Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure. International Journal of Molecular Sciences, 26(3), 1295. https://doi.org/10.3390/ijms26031295
Vancouver
Garmendia JV, De Sanctis CV, Hajdúch M, De Sanctis JB. Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure. International Journal of Molecular Sciences. 2025;26(3):1295. doi:10.3390/ijms26031295
BibTeX
@article{Garmendia2025,
author = {Garmendia, Jenny Valentina and De Sanctis, Claudia Valentina and Hajdúch, Marián and De Sanctis, Juan Bautista},
title = {Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {3},
pages = {1295},
doi = {10.3390/ijms26031295}
}
EUVIMED